Home: About Rhamnolipids
Natural & Organic
Source
Pseudomonas aeruginosa
History
Chemistry
Scientific References
Rhamnolipid Properties
Chemical
Biological
Applications
Ehanced Oil Recovery
Cosmetic
Environmental Cleanup
Pesticide
Pharmaceutical
Sludge Removal
Production Sources
Distributors

Hibiscus Hibiscus

Production Sources

Rhamnolipids are metabolic byproducts produced by a number of gram-negative bacteria.

Traditionally rhamnolipids are produced in small research amounts by laboratories from isolated strains of particular gram-negative bacteria.  These bacteria are often isolated from samples in the environment and grown in small batches for analysis and experimentation.  There are numerous research papers generated as a result of these small batch rhamnolipid experiments.

There are a few companies producing small amount of rhamnolipids for inclusion in their own products.  Usually they do not have excess capacity.  Often the rhamnolipids produced are impure with harmful contaminants that are normally produced as part of the bacteria’s normal metabolic process or part of the unmetabolized feedstock.  For most uses of rhamnolipids, the product quality is unacceptable.

Rhamnolipid Manufacturers

The primary source of production quantities of rhamnolipid is Rhamnolipid, Inc.

Rhamnolipid, Inc. has spent millions of dollars isolating strains of bacteria, researching feedstock, testing production methods, and testing purification methodologies.  The company has had numerous patented and trade secret breakthroughs that make it the highest quality and largest volume producer of rhamnolipids.

Rhamnolipid, Inc. supplies research and industrial quantities of rhamnolipids manufactured to the specifications of the customer:

Rhamnolipid Suppliers

The following companies sell rhamnolipid-based specialty products using rhamnolipids supplied by Rhamnolipid, Inc.:

Aurora Beauty Labs, Inc. is a provider of rhamnolipid-based cosmetics and toiletries.

BIOEOR, Inc. is a provider of rhamnolipid-based technology for the petroleum industry for enhanced oil recovery.

Paradigm Biomedical, Inc. develops and markets pharmaceutical products derived from rhamnolipids.


Terms of Use/Privacy PolicyCopyright © 2008-2010 All Rights Reserved, Rhamnolipid, Inc